The FH Global Summit is the only conference entirely devoted to the care and treatment of inherited cardiovascular disorders including familial hypercholesterolemia (FH) and high lipoprotein(a). Each year, this invitation only event brings together unique voices to inspire and advent change.The FH Global Summit brings together experts in cardiology, genetics, precision medicine, and public health to imagine new solutions alongside Nobel Laureates, clinical practitioners, individuals with FH and industry.
2020 FH Global Summit Session 5: New Frontiers of FH Care
FEBRUARY 17, 2021
Can gene editing with CRISPR technology help fight cardiovascular disease? Can looking beyond the known FH genes help personalize risk assessment? Join Dr. Kiran Musunuru, Penn Medicine, and Dr. Amit V. Khera, Broad Institute, as we discuss and debate.
Living with Homozygous Familial Hypercholesterolemia Today
FEBRUARY 25, 2021
Managing high cholesterol, possible heart disease and juggling life are just a few of the challenges people face living with Homozygous Familial Hypercholesterolemia (HoFH) the most severe form of familial hypercholesterolemia. Yet, today there is more hope than ever with new treatments and scientific advances for both adults and children with HoFH.
Join Dr. P. Barton Duell, Director of Lipid-Atherosclerosis Laboratory and Sterols Analysis Laboratory and LDL Apheresis Unit at Oregon Health and Science University, and Dr. Lisa Hudgins, Associate Professor of Pediatrics in Medicine at the Rogosin Institute/Weill Cornell Medical College, as they share the latest research and new treatments on the horizon.